Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Drug Delivery Company (DDC) is a biotechnology firm specializing in the development and commercialization of the Pheroid technology, a unique and versatile delivery system for various active ingredients. The Pheroid platform consists of sub-micron sized vesicles and micro-sponges that can encapsulate both hydrophilic and hydrophobic compounds, enhancing their stability, absorption, and bioavailability. DDC focuses on applying this technology across pharmaceuticals, nutraceuticals, and cosmeceuticals to improve the efficacy of existing and new treatments. The company operates primarily through a licensing and collaborative model, partnering with established industry players to integrate Pheroid into their product pipelines.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Drug Delivery Company.